With our substantial experience in advising some of the world's largest medtech, biotech and pharmaceutical companies, our Medical Devices Group is uniquely placed to offer specific and strategic solutions.
Rapid development of new technologies in the medical devices sector has brought exciting and innovative products to market to the benefit of patients around the world, but the shifting regulatory landscape has meant that the sector is facing increased challenges.
Whether a business is just starting out or is a large multinational, it will need to evaluate risks and opportunities arising from intellectual property rights, regulatory and compliance issues, data protection and product liability. The increasing use of mobile or networked devices brings new challenges in terms of security of devices. There are also commercial drivers which will influence pricing and advertising campaigns, R&D and collaboration agreements, corporate restructuring and financing, asset purchases or potential M&As.
All of this requires lawyers with deep sector knowledge who can offer strategic solutions and insight. With offices in Europe, Asia (including China), Australasia and the Middle East, we can help.
Our specialist Medical Devices Group comprises a multi-disciplinary, cross-jurisdictional team of experts. Our team advises on the following key areas, in addition to our broader full service offering provided by Bird & Bird.
We are delighted to announce that our Life Sciences team has won two awards at the 8th annual LMG European Life Sciences Awards 2020.
Bird & Bird LLP advised Materia on the acquisition of all shares in German licensed medicinal cannabis distributor Cannaktiv GmbH. The deal provides Materia – an international manufacturer and distributor of medicinal ...
We caught up with boomerang alumnus Stephan Waldheim about what his in-house experience taught him and why his natu… https://t.co/PYpXvDvkdW
We advised Elite World Group, the world's largest model management network, on the establishment of a new agency ca… https://t.co/TxsyNh1DSC
HMRC’s informal investigation powers have been confirmed by the Court of Appeal. Our Tax Disputes experts explore t… https://t.co/n9pz2Tp7Qi